Clinical characteristics

No. of patients

ARID1A

ATM

NF2

PTEN

STAG2

Mut

χ2

p

Mut

χ2

p

Mut

χ2

p

Mut

χ2

p

Mut

χ2

p

Total

262

Sex

Male

169

15

0.142

0.706

11

0.712

0.399

7

1.011

0.315

5

0.000

1.000

3

0.000

1.000

Female

93

7

3

1

3

2

Age

<60

134

14

1.500

0.221

7

0.008

0.930

5

0.086

0.769

2

1.307

0.253

4

0.725

0.394

≥60

128

8

7

3

6

1

Race

Asian

156

15

0.744

0.388

9

0.138

0.710

5

0.000

1.000

5

0.000

1.000

3

0.000

1.000

non-Asian

106

7

5

3

3

2

Pathological typing

HCC

225

19

0.270

1.000

13

0.584

0.747

7

0.921

1.000

6

2.200

0.347

3

4.294

0.179

ICC

34

3

1

1

2

2

cHCC-ICC

3

0

0

0

0

0

Primary site

Liver

228

19

0.000

1.000

13

0.067

0.796

1

0.000

1.000

6

0.244

0.622

3

1.308

0.253

Intrahepatic bile duct

34

3

1

1

2

2

Treatment type

Pharmaceutical therapy, NOS

132

11

0.001

0.970

7

0.001

0.977

5

0.114

0.736

4

0.000

1.000

3

0.000

1.000

Radiation therapy, NOS

130

11

7

3

4

2

T stage

T1 - T2

183

13

1.319

0.251

8

0.586

0.444

3

0.669

0.102

5

0.005

0.945

3

0.000

1.000

T3 - T4

79

9

6

5

3

2

M stage

M0

248

19

1.721

0.190

12

0.843

0.358

7

0.013

0.908

8

0.000

1.000

4

0.219

0.640

M1

14

3

2

1

0

1

N stage

N0

252

21

0.000

1.000

13

0.000

1.000

8

0.000

1.000

7

0.133

0.715

5

0.000

1.000

N1

10

1

1

0

1

0

Stage

I - II

177

13

0.785

0.375

8

0.316

0.574

3

2.134

0.144

5

0.000

1.000

3

0.000

1.000

III - IV

85

9

6

5

3

2